BOLD (BEEF IN AN OPTIMAL LEAN DIET) EFFECTS ON ESTAB & EMERGING CVD RISK FACTOR

大胆(最佳瘦肉饮食中的牛肉)对建立的影响

基本信息

项目摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Several clinical trials have shown that the incorporation of lean red meat in a Step I or AHA diet does not attenuate the reduction of traditional risk factors for cardiovascular disease (CVD). However, epidemiological data consistently correlates increased red meat consumption with increased incidence of CVD, most likely due to the beef choice in the reported diets of fattier meat or processed meats. We are proposing a cross-over design controlled feeding study to evaluate the effects of the incorporation of lean red meat in a heart healthy (DASH type) diet on established and emerging CVD risk factors. Eighty men and women split into two distinct populations, moderate hypercholesterolemic and hypertriglyceridemic, will be assigned four different diets for five weeks each - average American control (50% carbohydrates, 16% protein, 22% fat), DASH (50% carbohydrates, 18% protein, 28% fat), BOLD (50% carbohydrates, 18% protein, 28% fat, 5-7oz lean red meat ), BOLD+ (44% carbohydrates, 28% protein, 28% fat, 5-7oz lean red meat). We hypothesize that the BOLD and BOLD+ diets will yield changes in LDL-C similar to that seen during the DASH diet period. We also hypothesize that the BOLD and BOLD+ diet periods will produce better effects on HDL-C, TG and glucose homeostasis.
这个子项目是众多研究子项目之一

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

PENNY M KRIS-ETHERTON其他文献

PENNY M KRIS-ETHERTON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('PENNY M KRIS-ETHERTON', 18)}}的其他基金

WALNUT COMPONENTS VS WHOLE WALNUTS
核桃成分 VS 整核桃
  • 批准号:
    7951355
  • 财政年份:
    2009
  • 资助金额:
    $ 13.91万
  • 项目类别:
MUSHROOM
蘑菇
  • 批准号:
    7951351
  • 财政年份:
    2009
  • 资助金额:
    $ 13.91万
  • 项目类别:
THE EFFECTS OF PROCESSED TOMATOES ON ENDOTHELIUM AND PLATELET FUNCTION
加工番茄对内皮和血小板功能的影响
  • 批准号:
    7951332
  • 财政年份:
    2009
  • 资助金额:
    $ 13.91万
  • 项目类别:
HEALTHY FAT (DAG)
健康脂肪 (DAG)
  • 批准号:
    7951349
  • 财政年份:
    2009
  • 资助金额:
    $ 13.91万
  • 项目类别:
BOLD (BEEF IN AN OPTIMAL LEAN DIET) EFFECTS ON METABOLIC SYNDROME BOLD-X
BOLD(最佳瘦肉饮食中的牛肉)对代谢综合征的影响 BOLD-X
  • 批准号:
    7951347
  • 财政年份:
    2009
  • 资助金额:
    $ 13.91万
  • 项目类别:
EDUCATION PROGRAM TO TEACH WEIGHT LOSS
减肥教育计划
  • 批准号:
    7951323
  • 财政年份:
    2009
  • 资助金额:
    $ 13.91万
  • 项目类别:
GRAINS
谷物
  • 批准号:
    7951350
  • 财政年份:
    2009
  • 资助金额:
    $ 13.91万
  • 项目类别:
WEIGHT LOSS & CVD PREVENTION VIA WHOLE GRAIN DIET IN PEOPLE W METABOLIC SYNDROME
减肥
  • 批准号:
    7625826
  • 财政年份:
    2007
  • 资助金额:
    $ 13.91万
  • 项目类别:
EFFECTS OF A DIET RICH IN MACADAMIA NUTS ON CARDIOVASCULAR DISEASE RISK FACTORS
富含澳洲坚果的饮食对心血管疾病危险因素的影响
  • 批准号:
    7625833
  • 财政年份:
    2007
  • 资助金额:
    $ 13.91万
  • 项目类别:
EFFECTS OF MEAL OCCASION & PLANT STEROL MULTIPLE CVD RF IN MOD HYPERCHOLESTEROL
用餐场合的影响
  • 批准号:
    7625847
  • 财政年份:
    2007
  • 资助金额:
    $ 13.91万
  • 项目类别:

相似海外基金

A platform for rapidly generating live attenuated enterovirus vaccines
快速生成减毒肠道病毒活疫苗的平台
  • 批准号:
    24K02286
  • 财政年份:
    2024
  • 资助金额:
    $ 13.91万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
I-Corps: Translation potential of an efficient method to generate live-attenuated and replication-defective DNA viruses for vaccine development
I-Corps:一种有效方法的转化潜力,可生成用于疫苗开发的减毒活病毒和复制缺陷型 DNA 病毒
  • 批准号:
    2420924
  • 财政年份:
    2024
  • 资助金额:
    $ 13.91万
  • 项目类别:
    Standard Grant
Developing a robust native extracellular matrix to improve islet function with attenuated immunogenicity for transplantation
开发强大的天然细胞外基质,以改善胰岛功能,并减弱移植的免疫原性
  • 批准号:
    10596047
  • 财政年份:
    2023
  • 资助金额:
    $ 13.91万
  • 项目类别:
Live attenuated non-transmissible (LANT) Klebsiella pneumoniae vaccines
肺炎克雷伯氏菌减毒非传染性 (LANT) 活疫苗
  • 批准号:
    10742028
  • 财政年份:
    2023
  • 资助金额:
    $ 13.91万
  • 项目类别:
Protecting Pigs From Enzootic Pneumonia: Rational Design Of Safe Attenuated Vaccines.
保护猪免受地方性肺炎:安全减毒疫苗的合理设计。
  • 批准号:
    BB/X017540/1
  • 财政年份:
    2023
  • 资助金额:
    $ 13.91万
  • 项目类别:
    Research Grant
A “Goldilocks” live attenuated poultry vaccine for Infectious Coryza
用于传染性鼻炎的“Goldilocks”家禽减毒活疫苗
  • 批准号:
    LP210301365
  • 财政年份:
    2023
  • 资助金额:
    $ 13.91万
  • 项目类别:
    Linkage Projects
A novel live-attenuated Zika vaccine with a modified 5'UTR
一种带有改良 5UTR 的新型寨卡减毒活疫苗
  • 批准号:
    10730832
  • 财政年份:
    2023
  • 资助金额:
    $ 13.91万
  • 项目类别:
Combating melanoma with an attenuated bacterial therapeutic
用减毒细菌疗法对抗黑色素瘤
  • 批准号:
    10659841
  • 财政年份:
    2023
  • 资助金额:
    $ 13.91万
  • 项目类别:
L2M NSERC-Bioengineering attenuated Sclerotinia sclerotiorum strains as bioherbicide for cereal production and lawn management
L2M NSERC-生物工程减毒核盘菌菌株作为谷物生产和草坪管理的生物除草剂
  • 批准号:
    576545-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 13.91万
  • 项目类别:
    Idea to Innovation
Investigating Host and Viral Factors for Improved Design of Future Live Attenuated Vaccines for IBV
研究宿主和病毒因素以改进未来 IBV 减毒活疫苗的设计
  • 批准号:
    BB/V016067/1
  • 财政年份:
    2022
  • 资助金额:
    $ 13.91万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了